China Universal Asset Management »

Prime Medicine shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $81k 28k 2.92
2024-09-30 $89k 23k 3.87
2024-06-30 $73k 14k 5.14
2024-03-31 $157k 22k 7.00
2023-12-31 $100k 11k 8.86

More positions owned by China Universal Asset Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Alphabet Inc-cl A Common Stock (GOOGL)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Tesla Common Stock (TSLA)
Regeneron Pharmaceuticals Common Stock (REGN)
Netflix Common Stock (NFLX)
Taiwan Semiconductor-sp Adr (TSM)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Prime Medicine

Alphabet
ARK Investment Management
BlackRock
T. Rowe Price Investment Management
FMR
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Redmile Group
Millennium Management
MWG Management
T. Rowe Price Associates
Geode Capital Management
State Street Corporation
Vestal Point Capital

View all funds holding Prime Medicine